Ignite Creation Date:
2025-12-25 @ 12:58 AM
Ignite Modification Date:
2025-12-25 @ 11:12 PM
Study NCT ID:
NCT05493293
Status:
TERMINATED
Last Update Posted:
2024-04-12
First Post:
2022-08-05
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Extension Study to Evaluate the Safety and Tolerability of NBI-921352 When Used With Anti-seizure Medications in Adults With Focal Onset Seizures
Sponsor:
Neurocrine Biosciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-11-09
Start Date Type:
ACTUAL
Primary Completion Date:
2024-03-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-03-11
Completion Date Type:
ACTUAL
First Submit Date:
2022-08-05
First Submit QC Date:
None
Study First Post Date:
2022-08-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-10
Last Update Post Date:
2024-04-12
Last Update Post Date Type:
ACTUAL